Search Medical Condition
Please enter condition
Please choose location from dropdown
 

TBD, Turkey Clinical Trials

A listing of TBD, Turkey clinical trials actively recruiting patients volunteers.

RESULTS

Found (60031) clinical trials

Researchers at the University of Kentucky are inviting you to participate in a noninvasive, painless study that will involve: Recording of brain signals from electrodes on your scalp while you perform a repetitive hand grip task Brief peripheral nerve stimulation (PNS) in response to changes detected in your brain signals ...

Phase N/A

Doctors at Albert Einstein College of Medicine are seeking healthy volunteers, aged 21-60, to participate in a medical research study to better understand glucose metabolism and brain function. Inclusion Criteria: BP < 130/90 (+-2 meds) BMI < 35 Normal screening labs (CBC, chemistry, lft's PT/PTT) No CAD No first degree ...

Phase

We are conducting a treatment study to examine the use of Comprehensive Behavior Intervention for Tics (CBIT). CBIT is the current gold standard first-line behavioral treatment for children and adolescents with tic disorders.  The treatment includes three main components: (1) it helps patients become more aware of their tics, (2) ...

Phase N/A

This is a study to assess the pharmacokinetics (PK) of tedizolid phosphate and its active metabolite, tedizolid, and the safety of tedizolid phosphate following administration of a single IV (Part A) or oral suspension (Part B) administration to hospitalized participants ages 6 to less than 12 years (Groups 1 and ...

Phase

Do you or someone you know suffer from Diabetes? Are you taking Metformin or are Naïve to Diabetes medications? If so, you may be eligible to participate in a research study for an investigational Diabetes medication If you qualify you will receive all study-related examinations, lab work and study medications ...

Phase N/A

The purpose of this study is to compare the efficacy of BHV-4157 versus placebo on ataxia symptoms in subjects with spinocerebellar ataxia (SCA).

Phase N/A

The main purpose of this study is to evaluate the efficacy of the study drug known as LY3314814 in participants with mild Alzheimer's disease (AD) dementia.

Phase

The purpose of this study is to evaluate whether treatment with JNJ-54861911 slows cognitive decline compared with placebo treatment, as measured by a composite cognitive measure, the Preclinical Alzheimer Cognitive Composite (PACC), in amyloid-positive participants who are asymptomatic at risk for developing Alzheimer's dementia.

Phase N/A